Safety and Tolerability Study of CTx1000 In Participants With Amyotrophic Lateral Sclerosis
Clinical trial NCT07401121 · RECRUITING
Trial details
- NCT number
- NCT07401121
- Sponsor
- Celosia Therapeutics Pty Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-12
- Primary completion
- 2027-12-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.